Phio Pharmaceuticals (PHIO)

• Market cap: $12.1M
• 1 day: -1.75%
• 5 days: -14.5%
• 1 month: -29.11%
• 3 months: -48.62%
• 6 months: -54.66%
• Year to date: -41.05%
• 1 year: -60.98%
• 5 years: -99.6%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Employees: 5